Auspex Pharmaceuticals Shares Down 6.1% Following Weak Earnings (ASPX)
Auspex Pharmaceuticals (NASDAQ:ASPX)’s share price fell 6.1% during mid-day trading on Friday following a weaker than expected earnings announcement, American Banking & Market News reports. The company traded as low as $17.79 and last traded at $18.21, with a volume of 68,536 shares. The stock had previously closed at $19.40.
The company reported ($0.45) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.12.
A number of research firms have recently commented on ASPX. Analysts at Stifel Nicolaus reiterated a “buy” rating on shares of Auspex Pharmaceuticals in a research note on Friday. They now have a $40.00 price target on the stock, up previously from $39.00. Analysts at Robert W. Baird raised their price target on shares of Auspex Pharmaceuticals from $34.00 to $42.00 in a research note on Friday, July 11th. They now have an “outperform” rating on the stock.
The stock’s 50-day moving average is $20.73 and its 200-day moving average is $23.02. The company’s market cap is $443.9 million.
Auspex Pharmaceuticals, Inc is a biopharmaceutical company focused on the development and commercialization of medicines for the treatment of orphan diseases.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.